Machine Learning Model Accurately Diagnoses Celiac Disease
By Elana Gotkine HealthDay Reporter
THURSDAY, April 3, 2025 -- A machine learning algorithm can diagnose celiac disease from duodenal biopsies with accuracy comparable to pathologists, according to a study published online March 27 in the New England Journal of Medicine AI.
Florian Jaeckle, Ph.D., from the University of Cambridge in the United Kingdom, and colleagues developed a novel, accurate, machine learning-based diagnostic classifier to improve celiac disease diagnosis. The model was trained on 3,383 Whole-Slide-Images (WSI) of duodenal biopsies from four hospitals featuring five different WSI scanners and their clinical diagnoses. The model was trained using the multiple instance-learning paradigm in a weakly supervised manner, and it was assessed on an independent test set of 644 unseen scans. The model's predictions were compared to independent diagnoses from four specialist pathologists.
The researchers found that the model diagnosed celiac disease in the independent dataset with accuracy, sensitivity, and specificity exceeding 95 percent and an area under the receiver operating characteristic curve exceeding 99 percent, indicating that the model can potentially outperform pathologists. Comparing the model's predictions with those from independent pathologists, the results were statistically indistinguishable between pathologist-pathologist and pathologist-model interobserver agreement (>96 percent).
"This is the first time artificial intelligence has been shown to diagnose as accurately as an experienced pathologist whether an individual has celiac or not," Jaeckle said in a statement. "Because we trained it on data sets generated under a number of different conditions, we know that it should be able to work in a wide range of settings, where biopsies are processed and imaged differently."
Two authors disclosed ties to the biotechnology research industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-04 06:00
Read more

- People With Disabilities Often Feel Disrespected by Health Care Workers
- Merck’s Investigational Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared to Intravenous (IV) Keytruda® (pembrolizumab) in Pivotal 3475A-D77 Trial
- Two-Drug Combo Lowers Cholesterol Better Than Statins Alone
- Osteoarthritis Burden Increasing Among Postmenopausal Women
- COVID-19 Vaccination Not Linked to Major Structural Birth Defects
- Healthier Diets, Lower Waist-to-Hip Ratio in Midlife Improve Later Cognitive Health
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions